Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Tirzepatide may be more effective than semaglutide or liraglutide for weight loss, as it has a dual mechanism of action. Semaglutide has the longest half-life of the three, which may provide ...

Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity and prediabetes.

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

After a second investigation, the FDA announced tirzepatide will no longer be ... remain on the FDA drug shortage list, including dulaglutide (Trulicity, Eli Lilly), semaglutide (Ozempic/Wegovy ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

The FDA announced that the tirzepatide injection shortage is resolved ... Meanwhile, other GLP-1 drugs, including dulaglutide, semaglutide and liraglutide, remain in shortage.